ESR1 and triple-negative breast carcinoma: Here we will discuss the emerging evidence for the role that UCHL1 plays in the regulation of ER and the Transforming Growth Factor beta (TGF-β) pathway, dysregulation of which impacts the development of aggressive forms of breast cancer (ER− and triple-negative breast cancer) and also development of endocrine resistance.